Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Jun;12(3):230-7.
doi: 10.1111/j.1399-3062.2009.00490.x. Epub 2010 Jan 11.

Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study

M Winkler  1 , J Pratschke, U Schulz, S Zheng, M Zhang, W Li, M Lu, D Sgarabotto, G Sganga, P Kaskel, S Chandwani, L Ma, J Petrovic, M Shivaprakash
Affiliations
Multicenter Study

Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study

M Winkler et al. Transpl Infect Dis. 2010 Jun.

Abstract

Objective: This study was designed to determine clinical outcomes with caspofungin in patients with proven or probable invasive fungal infection (IFI) after a solid organ transplant (SOT) procedure.

Methods: In this retrospective observational study, data were collected for a single episode of IFI in patients with an SOT between January 2004 and June 2007. Response was determined by the investigator as favorable (complete or partial) or unfavorable (stable disease or failure) at the end of caspofungin therapy (EOCT). The primary effectiveness population was the proportion of patients who received >or=5 doses of caspofungin (modified all-patients-treated population). Safety was assessed for patients who received >or=1 dose of caspofungin.

Results: A total 81 of patients from 13 sites in China, Germany, Italy, and the United Kingdom were enrolled, including 49 (60%) liver, 22 (27%) heart, 5 (6%) lung, 2 (2%) kidney, 2 (2%) liver and kidney, and 1 (1%) pancreas and kidney recipients. Candidiasis was diagnosed in 64/81 patients (79%) and aspergillosis in 22/81 patients (27%). Most patients received caspofungin monotherapy (75%). Caspofungin was given as first-line therapy to 59 (73%) patients. The overall favorable response at EOCT was 87% (58/67; 95% confidence interval [CI]: 76%, 94%), with favorable responses in 88% (43/49; 95% CI: 75%, 95%) of patients receiving caspofungin monotherapy and 83% (15/18; 95% CI: 59%, 96%) of patients receiving combination therapy with caspofungin (modified all-patients-treated population). Response by type of SOT was as follows: liver 87% (39/45), heart 93% (14/15), kidney 100% (5/5), and lung 50% (2/4). An overall survival rate (all-patients-treated) of 69% (56/81; 95% CI: 59%, 79%) was observed at 7 days post EOCT. No serious drug-related adverse events were reported.

Conclusion: In this study, caspofungin was effective and well tolerated in the treatment of IFIs involving SOT recipients.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Patel R, Portela D, Badley AD, et al. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation. 1996;62(7):926–934. - PubMed
    1. Solé A, Salavert M. Fungal infections after lung transplantation. Transplant Rev (Orlando) 2008;22(2):89–104. - PubMed
    1. Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis. 2003;37(2):221–229. - PubMed
    1. Miller LW, Naftel DC, Bourge RC, et al. Infection after heart-transplantation – a multiinstitutional study. J Heart Lung Transplant. 1994;13(3):381–393. - PubMed
    1. Alexander BD, Tapson VF. Infectious complications of lung transplantation. Transpl Infect Dis. 2001;3(3):128–137. - PubMed

Publication types

MeSH terms